FDA Further Limits Johnson & Johnson Covid Vaccine
The agency said the move reflected an updated analysis of the risk of a rare but serious blood-clotting condition in people who get the vaccine.
Full Article
FDA Further Limits Johnson & Johnson Covid Vaccine
NYTimes.com
0 shares
1 views
- More about:
Food and Drug Administration- COVID-19 vaccine
You might like
Related news coverage
Citing Safety Concerns, F.D.A. Further Limits J.&J. Covid Vaccine
NYTimes.com
The agency said the move reflected an updated analysis of the risk of a rare but serious blood-clotting condition. Here’s the..
-
Covid-19 vaccine: US FDA limits use of Johnson and Johnson due to blood clot risk
DNA
-
US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk
Zee News
-
FDA limits use of Johnson and Johnson's Janssen COVID-19 vaccine
Upworthy
-
FDA puts strict limits on Johnson & Johnson Covid-19 vaccine
Upworthy